The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine And Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.
We will have over 600 end users representing internationally renowned research And academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
Our 7th Annual Single Cell Analysis Congress will include over 45 case studies and presentations focused on the developments in Single Cell Analysis, Drug Discovery and Therapeutic Development and Clinical Development.
Discussion Workshop and Breakfast: 10x Genomics Platform, Technologies Overview and Updates on The Human Cell Atlas Project.
Pharma focus: the use of single cell technologies in drug discovery and development as well as clinical development.
Healthcare focus: benchmarking RNA Seq sequencing technologies in the clinic, biopsies and single cell analyses to improve stratification of patient and diagnosis.
Discover the latest solutions single cell analysis: in sample preparation, single cell isolation, capture And purification, RNA processing and splicing, gene regulation, bioinformatics management and workflow analysis.
Registration available from: USD 299.0
Speakers: Remco Loos, Senior Principal Scientist, Celgene, Jean-Christophe Marine, Professor, Director VIB Center for CancerBiology (CCB), Laboratory for Molecular Cancer Biology, Department of Oncology, KULeuven, Jan Cools, Professor KU Leuven, Center for Human Genetics, Group Leader VIB, Center for Cancer Biology, Akos Vertes, Professor of Chemistry, Professor of Biochemistry And Molecular Biology, George Washington University, Marcelo Nollmann, Professor CNRS, Center for Structural Biochemistry, Montpellier